Selective inhibition of miR-21 by phage display screened peptide

Nucleic Acids Research

Volumn 43, Issue 8, 2015, Pages 4342-4352

  Bose, Debojit ^a   Nahar, Smita ^a,b   Rai, Manish Kumar ^a,b   Ray, Arjun ^a,b   Chakraborty, Kausik ^a,b   Maiti, Souvik ^a,b,c  

^a CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

^b ACADEMY OF SCIENTIFIC AND INNOVATIVE RESEARCH ACSIR   (India)

^c NATIONAL CHEMICAL LABORATORY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; GENOMIC DNA; MICRORNA 21; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; SMALL UNTRANSLATED RNA; ANTINEOPLASTIC AGENT; MICRORNA; MIRN21 MICRORNA, HUMAN; NUCLEOTIDE; PEPTIDE; RNA PRECURSOR;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; DEREGULATION; DOWN REGULATION; FLUORESCENCE SPECTROSCOPY; GENE CONTROL; GENE EXPRESSION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MODULATION; PEPTIDE ANALYSIS; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; ANTAGONISTS AND INHIBITORS; BINDING SITE; CELL LINE; CELL MOTION; CELL SURFACE DISPLAY; CHEMISTRY; DRUG EFFECTS; MCF 7 CELL LINE; METABOLISM; NEOPLASM; PATHOLOGY; TUMOR INVASION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BINDING SITES; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; CELL SURFACE DISPLAY TECHNIQUES; MCF-7 CELLS; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASMS; NUCLEOTIDES; PEPTIDES; RNA PRECURSORS;

EID: 84930224882     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkv185     Document Type: Article

References (55)

1. Bartel, D.P. (2009) MicroRNAs: target recognition and regulatory functions. Cell, 136, 215-233.
2. Kim, V.N., Han, J. and Siomi, M.C. (2009) Biogenesis of small RNAs in animals. Nat. Rev. Mol. Cell Biol., 10, 126-139.
3. Friedman, R.C., Farh, K.K., Burge, C.B. and Bartel, D.P. (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res., 19, 92-105.
4. Abbott, A.L. (2011) Uncovering new functions for microRNAs in Caenorhabditis elegans. Curr. Biol., 21, R668-R671.
5. Contreras, J. and Rao, D.S. (2012) MicroRNAs in inflammation and immune responses. Leukemia, 26, 404-413.
6. Mendell, J.T. and Olson, E.N. (2012) MicroRNAs in stress signaling and human disease. Cell, 148, 1172-1187.
7. Tiscornia, G. and Izpisua Belmonte, J.C. (2010) MicroRNAs in embryonic stem cell function and fate. Genes Dev., 24, 2732-2741.
8. Esteller, M. (2011) Non-coding RNAs in human disease. Nat. Rev. Genet., 12, 861-874.
9. Rottiers, V. and Naar, A.M. (2012) MicroRNAs in metabolism and metabolic disorders. Nat. Rev. Mol. Cell Biol., 13, 239-250.
10. Zampetaki, A. and Mayr, M. (2012) MicroRNAs in vascular and metabolic disease. Circ. Res., 110, 508-522.
11. Calin, G.A. and Croce, C.M. (2006) MicroRNA signatures in human cancers. Nat. Rev. Cancer, 6, 857-866.
12. Olson, P., Lu, J., Zhang, H., Shai, A., Chun, M.G., Wang, Y., Libutti, S.K., Nakakura, E.K., Golub, T.R. and Hanahan, D. (2009) MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer. Genes Dev., 23, 2152-2165.
13. Liu, H. (2012) MicroRNAs in breast cancer initiation and progression. Cell. Mol. Life Sci., 69, 3587-3599.
14. Boutla, A., Delidakis, C. and Tabler, M. (2003) Developmental defects by antisense-mediated inactivation of micro-RNAs 2 and 13 in Drosophila and the identification of putative target genes. Nucleic Acids Res., 31, 4973-4980.
15. Ebert, M.S., Neilson, J.R. and Sharp, P.A. (2007) MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat. Methods, 4, 721-726.
16. Jadhav, V.M., Scaria, V. and Maiti, S. (2009) Antagomirzymes: oligonucleotide enzymes that specifically silence microRNA function. Angew. Chem. Int. Ed. Engl., 48, 2557-2560.
17. Castanotto, D. and Rossi, J.J. (2009) The promises and pitfalls of RNA-interference-based therapeutics. Nature, 457, 426-433.
18. Bose, D., Jayaraj, G., Suryawanshi, H., Agarwala, P., Pore, S.K., Banerjee, R. and Maiti, S. (2012) The tuberculosis drug streptomycin as a potential cancer therapeutic: inhibition of miR-21 function by directly targeting its precursor. Angew. Chem. Int. Ed. Engl., 51, 1019-1023.
19. Bose, D., Jayaraj, G.G., Kumar, S. and Maiti, S. (2013) A molecular-beacon-based screen for small molecule inhibitors of miRNA maturation. ACS Chem. Biol., 8, 930-938.
20. Davies, B.P. and Arenz, C. (2006) A homogenous assay for micro RNA maturation. Angew. Chem. Int. Ed. Engl., 45, 5550-5552.
21. Deiters, A. (2010) Small molecule modifiers of the microRNA and RNA interference pathway. AAPS J., 12, 51-60.
22. Diaz, J.P., Chirayil, R., Chirayil, S., Tom, M., Head, K.J. and Luebke, K.J. (2014) Association of a peptoid ligand with the apical loop of pri-miR-21 inhibits cleavage by Drosha. RNA, 20, 528-539.
23. Gumireddy, K., Young, D.D., Xiong, X., Hogenesch, J.B., Huang, Q. and Deiters, A. (2008) Small-molecule inhibitors of microrna miR-21 function. Angew. Chem. Int. Ed. Engl., 47, 7482-7484.
24. Murata, A., Fukuzumi, T., Umemoto, S. and Nakatani, K. (2013) Xanthone derivatives as potential inhibitors of miRNA processing by human Dicer: targeting secondary structures of pre-miRNA by small molecules. Bioorg. Med. Chem. Lett., 23, 252-255.
25. Shi, Z., Zhang, J., Qian, X., Han, L., Zhang, K., Chen, L., Liu, J., Ren, Y., Yang, M., Zhang, A. et al. (2013) AC1MMYR2, an inhibitor of Dicer-mediated biogenesis of oncomir miR-21, reverses epithelial-mesenchymal transition and suppresses tumor growth and progression. Cancer Res., 73, 5519-5531.
26. Tan, G.S., Chiu, C.H., Garchow, B.G., Metzler, D., Diamond, S.L. and Kiriakidou, M. (2012) Small molecule inhibition of RISC loading. ACS Chem. Biol., 7, 403-410.
27. Velagapudi, S.P. and Disney, M.D. (2014) Two-dimensional combinatorial screening enables the bottom-up design of a microRNA-10b inhibitor. Chemical Commun., 50, 3027-3029.
28. Velagapudi, S.P., Gallo, S.M. and Disney, M.D. (2014) Sequence-based design of bioactive small molecules that target precursor microRNAs. Nat. Chem. Biol., 10, 291-297.
29. Watashi, K., Yeung, M.L., Starost, M.F., Hosmane, R.S. and Jeang, K.T. (2010) Identification of small molecules that suppress microRNA function and reverse tumorigenesis. J. Biol. Chem., 285, 24707-24716.
30. Xiao, J., Yang, B., Lin, H., Lu, Y., Luo, X. and Wang, Z. (2007) Novel approaches for gene-specific interference via manipulating actions of microRNAs: examination on the pacemaker channel genes HCN2 and HCN4. J. Cell. Physiol., 212, 285-292.
31. Young, D.D., Connelly, C.M., Grohmann, C. and Deiters, A. (2010) Small molecule modifiers of microRNA miR-122 function for the treatment of hepatitis C virus infection and hepatocellular carcinoma. J. Am. Chem. Soc., 132, 7976-7981.
32. Gelman, M.A., Richter, S., Cao, H., Umezawa, N., Gellman, S.H. and Rana, T.M. (2003) Selective binding of TAR RNA by a Tat-derived beta-peptide. Organic Lett., 5, 3563-3565.
33. Medina, P.P., Nolde, M. and Slack, F.J. (2010) OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature, 467, 86-90.
34. Lou, Y., Cui, Z., Wang, F., Yang, X. and Qian, J. (2011) miR-21 down-regulation promotes apoptosis and inhibits invasion and migration abilities of OVCAR3 cells. Clin. Invest. Med., 34, E281-E289.
35. Yan, L.X., Wu, Q.N., Zhang, Y., Li, Y.Y., Liao, D.Z., Hou, J.H., Fu, J., Zeng, M.S., Yun, J.P., Wu, Q.L. et al. (2011) Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivo tumor growth. Breast Cancer Res., 13, R2-R14.
36. Zhu, Q., Wang, Z., Hu, Y., Li, J., Li, X., Zhou, L. and Huang, Y. (2012) miR-21 promotes migration and invasion by the miR-21-PDCD4-AP-1 feedback loop in human hepatocellular carcinoma. Oncol. Rep., 27, 1660-1668.
37. Lamichhane, T.N., Abeydeera, N.D., Duc, A.C., Cunningham, P.R. and Chow, C.S. (2011) Selection of peptides targeting helix 31 of bacterial 16S ribosomal RNA by screening M13 phage-display libraries. Molecules, 16, 1211-1239.
38. Li, M., Duc, A.C., Klosi, E., Pattabiraman, S., Spaller, M.R. and Chow, C.S. (2009) Selection of peptides that target the aminoacyl-tRNA site of bacterial 16S ribosomal RNA. Biochemistry, 48, 8299-8311.
39. Thevenet, P., Shen, Y., Maupetit, J., Guyon, F., Derreumaux, P. and Tuffery, P. (2012) PEP-FOLD: an updated de novo structure prediction server for both linear and disulfide bonded cyclic peptides. Nucleic Acids Res., 40, W288-W293.
40. Van Der Spoel, D., Lindahl, E., Hess, B., Groenhof, G., Mark, A.E. and Berendsen, H.J. (2005) GROMACS: fast, flexible, and free. J. Comput. Chem., 26, 1701-1718.
41. Brooks, B.R., Brooks, C.L. 3rd, Mackerell, A.D. Jr, Nilsson, L., Petrella, R.J., Roux, B., Won, Y., Archontis, G., Bartels, C., Boresch, S. et al. (2009) CHARMM: the biomolecular simulation program. J. Comput. Chem., 30, 1545-1614.
42. Orozco, M., Noy, A. and Perez, A. (2008) Recent advances in the study of nucleic acid flexibility by molecular dynamics. Curr. Opin. Struct. Biol., 18, 185-193.
43. Sapay, N. and Tieleman, D.P. (2011) Combination of the CHARMM27 force field with united-atom lipid force fields. J. Comput. Chem., 32, 1400-1410.
44. Parisien, M. and Major, F. (2008) The MC-Fold and MC-Sym pipeline infers RNA structure from sequence data. Nature, 452, 51-55.
45. Pierce, B.G., Wiehe, K., Hwang, H., Kim, B.H., Vreven, T. and Weng, Z. (2014) ZDOCK server: interactive docking prediction of protein-protein complexes and symmetric multimers. Bioinformatics, 30, 1771-1773.
46. Regulski, E.E. and Breaker, R.R. (2008) In-line probing analysis of riboswitches. Methods Mol. Biol., 419, 53-67.
47. Livak, K.J. and Schmittgen, T.D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 25, 402-408.
48. Landgraf, P., Rusu, M., Sheridan, R., Sewer, A., Iovino, N., Aravin, A., Pfeffer, S., Rice, A., Kamphorst, A.O., Landthaler, M. et al. (2007) A mammalian microRNA expression atlas based on small RNA library sequencing. Cell, 129, 1401-1414.
49. Ribas, J., Ni, X., Castanares, M., Liu, M.M., Esopi, D., Yegnasubramanian, S., Rodriguez, R., Mendell, J.T. and Lupold, S.E. (2012) A novel source for miR-21 expression through the alternative polyadenylation of VMP1 gene transcripts. Nucleic Acids Res., 40, 6821-6833.
50. Brown, M., Suryawanshi, H., Hafner, M., Farazi, T.A. and Tuschl, T. (2013) Mammalian miRNA curation through next-generation sequencing. Front. Genet., 4, 1-8.
51. Wang, X. and Liu, X.S. (2011) Systematic Curation of miRBase Annotation Using Integrated Small RNA High-Throughput Sequencing Data for C. elegans and Drosophila. Front. Genet., 2, 1-14.
52. Frankel, L.B., Christoffersen, N.R., Jacobsen, A., Lindow, M., Krogh, A. and Lund, A.H. (2008) Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J. Biol. Chem., 283, 1026-1033.
53. Yang, H.S., Jansen, A.P., Komar, A.A., Zheng, X., Merrick, W.C., Costes, S., Lockett, S.J., Sonenberg, N. and Colburn, N.H. (2003) The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation. Mol. Cell. Biol., 23, 26-37.
54. Zhen, Y., Liu, Z., Yang, H., Yu, X., Wu, Q., Hua, S., Long, X., Jiang, Q., Song, Y., Cheng, C. et al. (2013) Tumor suppressor PDCD4 modulates miR-184-mediated direct suppression of C-MYC and BCL2 blocking cell growth and survival in nasopharyngeal carcinoma. Cell Death Dis., 4, e872.
55. Zhu, S., Wu, H., Wu, F., Nie, D., Sheng, S. and Mo, Y.Y. (2008) MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res., 18, 350-359.